SCHEMBL9265002

SCHEMBL9265002

COc1cc(NS(=O)(=O)c2cccc(Cl)c2C)ccc1-n1cnc(C)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 13/20 0.69
▸ PSEN2 P49810 13/20 0.69
▸ APH1B Q8WW43 13/20 0.69
▸ NCSTN Q92542 13/20 0.69
▸ APH1A Q96BI3 13/20 0.69
▸ PSENEN Q9NZ42 13/20 0.69
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ CCR4 P51679 1/20 0.45
▸ KDM1A O60341 1/20 0.45
▸ GPR142 Q7Z601 1/20 0.44
▸ BRD4 O60885 1/20 0.44
▸ BRD2 P25440 1/20 0.44
▸ BRPF1 P55201 1/20 0.44
▸ BRD3 Q15059 1/20 0.44
▸ BRDT Q58F21 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HSD11B1 P28845 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8817705 0.92 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819732 0.92 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8818013 0.89 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9265343 0.88 PSEN1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819517 0.87 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8818255 0.86 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9260042 0.86 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8817371 0.86 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8818800 0.85 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9263098 0.85 PSEN1 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 — — US disclosed
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP PSEN1 9/4885PSEN2 20/4885APH1B 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback